SEC Form D private-offering filing

Affinia Therapeutics Inc.

Name: Affinia Therapeutics Inc. - new SEC Form D private-offering filing, Waltham, MA
Published: 2025-10-14

A new SEC Form D private-offering notice from Waltham, MA, a $45,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Affinia Therapeutics Inc. site↗ Verified via SEC Form D

Preclinical biotech developing AAV based gene therapies for cardiovascular and neurological diseases, including a lead program for BAG3 associated dilated cardiomyopathy.

Filed 2025-10-14Filed to raise $45,000,000First money in 2025-09-16Raised so far $13,268,335HQ (as filed) Waltham, MASector Biotech ✓Stage (inferred) GrowthCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified affiniatx.com↗Named in the filing 10 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.